MST-997

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Neoplasms

Phase 1

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

TerminatedNCT00088647

Wyeth is now a wholly owned subsidiary of PfizerNeoplasms

Updated: 2006-12-08

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

TerminatedNCT00277836

Wyeth is now a wholly owned subsidiary of PfizerNeoplasms

Target: 60Updated: 2006-12-08